Voyager Therapeutics (VYGR)

Voyager Therapeutics Financial Statements


Voyager Therapeutics Financial Overview

Voyager Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.573; its P/E ratio is -3.82; Voyager Therapeutics is scheduled to report earnings on November 2, 2022, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 712.00K$ 658.00K$ 28.07M$ 1.48M$ 1.36M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -19.37M$ -21.35M$ 5.70M$ -25.15M$ -28.59M
EBITDA$ -18.16M$ -18.54M$ 7.18M$ -23.92M$ -27.40M
Net Income Common Stockholders$ -19.09M$ -21.32M$ 5.71M$ -25.14M$ -30.12M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 121.50M$ 132.54M$ 142.98M$ 148.06M$ 161.51M
Total Assets$ 188.60M$ 224.18M$ 193.85M$ 184.77M$ 208.73M
Total Debt$ 24.27M$ 31.80M$ 41.32M$ 43.20M$ 44.88M
Net Debt$ -97.23M$ -100.74M$ -101.66M$ -104.85M$ -116.63M
Total Liabilities$ 128.55M$ 148.25M$ 98.80M$ 97.35M$ 98.19M
Stockholders Equity$ 60.05M$ 75.93M$ 87.42M$ 95.06M$ 110.54M
Cash Flow
Free Cash Flow$ -19.73M$ 34.39M$ 10.85M$ -21.37M$ -22.94M
Operating Cash Flow$ -18.48M$ 34.43M$ 11.20M$ -20.71M$ -22.72M
Investing Cash Flow$ -36.13M$ -20.00M$ -5.46M$ 14.34M$ 22.41M
Financing Cash Flow$ 807.00K$ 12.00K$ 227.00K$ 0.00$ 357.00K
Currency in USD

Voyager Therapeutics Earnings and Revenue History

Voyager Therapeutics Debt to Assets

Voyager Therapeutics Cash Flow

Voyager Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis